Data presented here show that PD-1 blockade could in addition indirectly contribute to tumor-specific CD8 T cell proliferation through in situ reactivation of tumor Ag–specific PD-1hiCD39+ CD4 Tconv TILs and DC maturation. This evidence concerns the gene CD8A and neoplasm.